Cutting edge medicine and mandatory taxes: A clash of 2 worlds, a detriment to us all
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Snapshot:
- ...
Equitable access to clinical trials (EACT): Eliminating the financial burden for patients
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Snapshot:
Sponsor Checklist: deciding between purpose-built IRT or EDC with IRT add-on
10 questions to help identify an IRT solution
As the complexity of clinical trials continues to...
Why participant reimbursement solutions are key to boosting diversity in clinical trials
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Clinical...
When clinical trial sites don’t get paid
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Snapshot:
Two years of AI learning: Streamlining clinical trials today for future advancements
Author: Heather Nonnemacher, Associate Director, Services Solutions
The greatest impact of tax in clinical research
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Snapshot:
FDA’s updated draft guidance on reporting of diversity data in clinical trials
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
In January...
Improving patient comprehension through eConsent: a win-win for patients, sites, and sponsors
Author: Amanda Howley, Director of Services Delivery
Four steps to forge strong partnerships between CROs, sponsors, and technology vendors
Author: Anthony Encarnacao, Vice President, Global Partnerships
Snapshot: Understanding...